Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
NDC API
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Cg100649
1. 301692-76-2
2. Cg100649
3. 4-(3-(3-fluorophenyl)-5,5-dimethyl-4-oxo-4,5-dihydrofuran-2-yl)benzenesulfonamide
4. Cg-100649
5. Ij34d6ypao
6. Cg 100649
7. 4-[3-(3-fluorophenyl)-5,5-dimethyl-4-oxofuran-2-yl]benzenesulfonamide
8. 4-(3-(3-fluorophenyl)-5,5-dimethyl-4-oxo-4,5-dihydrofuran-2-yl)-benzenesulfonamide
9. 4-[3-(3-fluorophenyl)-5,5-dimethyl-4-oxidanylidene-furan-2-yl]benzenesulfonamide
10. Benzenesulfonamide, 4-(3-(3-fluorophenyl)-4,5-dihydro-5,5-dimethyl-4-oxo-2-furanyl)-
11. Polmacoxib [usan:inn]
12. Unii-ij34d6ypao
13. Polmacoxib [usan]
14. Acelex (s. Korea)
15. Polmacoxibcg100649
16. Polmacoxib [inn]
17. Polmacoxib (usan/inn)
18. Polmacoxib [who-dd]
19. Chembl166863
20. Gtpl8316
21. Schembl3233093
22. Ex-a601
23. Dtxsid901029389
24. Zinc589683
25. Bcp15550
26. Bdbm50474760
27. Akos025149767
28. Db12399
29. Sb17177
30. Da-42861
31. Hy-16726
32. Cs-0012326
33. Ft-0700281
34. D10656
35. A857030
36. J-690277
37. Q19598695
38. Cg100649; Cg-100649; Cg 100649
39. 2-(4-tert-butylphenyl)-1h-benzimidazole, 2-[4-(1,1-dimethylethyl)phenyl]-1h-benzimidazole
40. 5-{4-(aminosulfonyl)phenyl}-2,2-dimethyl-4-(3-fluorophenyl)-3(2h)-furanone
41. 1427301-99-2
| Molecular Weight | 361.4 g/mol |
|---|---|
| Molecular Formula | C18H16FNO4S |
| XLogP3 | 2.6 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 3 |
| Exact Mass | 361.07840733 g/mol |
| Monoisotopic Mass | 361.07840733 g/mol |
| Topological Polar Surface Area | 94.8 Ų |
| Heavy Atom Count | 25 |
| Formal Charge | 0 |
| Complexity | 672 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
M - Musculo-skeletal system
M01 - Antiinflammatory and antirheumatic products
M01A - Antiinflammatory and antirheumatic products, non-steroids
M01AH - Coxibs
M01AH07 - Polmacoxib
Digital Content 
NEWS #PharmaBuzz
Market Place
ABOUT THIS PAGE
A Polmacoxib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Polmacoxib, including repackagers and relabelers. The FDA regulates Polmacoxib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Polmacoxib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Polmacoxib manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Polmacoxib supplier is an individual or a company that provides Polmacoxib active pharmaceutical ingredient (API) or Polmacoxib finished formulations upon request. The Polmacoxib suppliers may include Polmacoxib API manufacturers, exporters, distributors and traders.
click here to find a list of Polmacoxib suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Polmacoxib Drug Master File in Korea (Polmacoxib KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Polmacoxib. The MFDS reviews the Polmacoxib KDMF as part of the drug registration process and uses the information provided in the Polmacoxib KDMF to evaluate the safety and efficacy of the drug.
After submitting a Polmacoxib KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Polmacoxib API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Polmacoxib suppliers with KDMF on PharmaCompass.
Polmacoxib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Polmacoxib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Polmacoxib GMP manufacturer or Polmacoxib GMP API supplier for your needs.
A Polmacoxib CoA (Certificate of Analysis) is a formal document that attests to Polmacoxib's compliance with Polmacoxib specifications and serves as a tool for batch-level quality control.
Polmacoxib CoA mostly includes findings from lab analyses of a specific batch. For each Polmacoxib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Polmacoxib may be tested according to a variety of international standards, such as European Pharmacopoeia (Polmacoxib EP), Polmacoxib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Polmacoxib USP).
LOOKING FOR A SUPPLIER?
